|
G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
decreases expression
|
EXP
|
Dimethylformamide results in decreased expression of ABCB1B mRNA
|
CTD |
PMID:12883083 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199
|
|
G
|
Adgre1
|
adhesion G protein-coupled receptor E1
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of ADGRE1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of ADGRE1 protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,242,474...2,398,000
|
|
G
|
Arg1
|
arginase 1
|
decreases expression
|
ISO
|
Dimethylformamide results in decreased expression of ARG1 mRNA
|
CTD |
PMID:37995826 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO
|
Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of BAX protein]
|
CTD |
PMID:29984871 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
multiple interactions increases expression
|
EXP ISO
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein] Dimethylformamide results in increased expression of BCL2L1 protein
|
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased cleavage of CASP1 protein]; Dimethylformamide results in increased expression of and results in increased cleavage of CASP1 protein
|
CTD |
PMID:37995826 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases expression
|
EXP ISO
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased activity of CASP3 protein CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]
|
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
ISO
|
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]
|
CTD |
PMID:29984871 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]
|
CTD |
PMID:29984871 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions increases expression
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of CCL2 mRNA]
|
CTD |
PMID:37995826 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G
|
Cd163
|
CD163 molecule
|
decreases expression
|
ISO
|
Dimethylformamide results in decreased expression of CD163 mRNA
|
CTD |
PMID:37995826 |
|
NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:157,085,093...157,117,878
|
|
G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
increases phosphorylation multiple interactions
|
ISO
|
Dimethylformamide results in increased phosphorylation of CHUK protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of CHUK protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
affects metabolic processing increases oxidation increases metabolic processing increases expression multiple interactions increases abundance increases response to substance
|
ISO EXP
|
CYP2E1 protein polymorphism affects the metabolism of Dimethylformamide CYP2E1 protein results in increased oxidation of Dimethylformamide CYP2E1 protein affects the metabolism of Dimethylformamide CYP2E1 protein results in increased metabolism of Dimethylformamide Dimethylformamide results in increased expression of CYP2E1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in decreased activity of CYP2E1 protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein]; Dimethylformamide results in decreased expression of and results in decreased activity of CYP2E1 protein CYP2E1 polymorphism results in increased abundance of Dimethylformamide metabolite CYP2E1 protein results in increased susceptibility to Dimethylformamide
|
CTD |
PMID:9817075 PMID:10207612 PMID:11305777 PMID:15772367 PMID:29984871 PMID:31501917 PMID:37995826 More...
|
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
EXP
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of DDIT3 mRNA
|
CTD |
PMID:20097184 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
EXP
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of EIF2AK3 protein modified form
|
CTD |
PMID:20097184 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of GCLC protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of GCLC protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
increases activity multiple interactions
|
ISO
|
Dimethylformamide results in increased activity of GOT1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of GOT1 protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases activity
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]
|
CTD |
PMID:31501917 PMID:37995826 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
decreases expression
|
EXP
|
Dimethylformamide results in decreased expression of GSR mRNA
|
CTD |
PMID:12883083 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of H2AX protein
|
CTD |
PMID:26387567 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases expression increases expression
|
ISO
|
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein] Dimethylformamide results in decreased expression of HMOX1 mRNA; Dimethylformamide results in decreased expression of HMOX1 protein Dimethylformamide results in increased expression of HMOX1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of HMOX1 protein]
|
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
multiple interactions increases expression
|
EXP ISO
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSP90B1 protein CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein]
|
CTD |
PMID:20097184 PMID:31501917 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
EXP
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA; [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein
|
CTD |
PMID:20097184 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of IL1B mRNA allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased cleavage of IL1B protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of IL1B protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of IL1B mRNA]; Dimethylformamide results in increased expression of and results in increased cleavage of IL1B protein; Dimethylformamide results in increased expression of and results in increased secretion of IL1B protein
|
CTD |
PMID:37995826 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of IL6 protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of IL6 mRNA]; Dimethylformamide results in increased expression of and results in increased secretion of IL6 protein
|
CTD |
PMID:37995826 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Ldha
|
lactate dehydrogenase A
|
multiple interactions increases activity
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of LDHA protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G
|
Ltf
|
lactotransferrin
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of LTF mRNA
|
CTD |
PMID:18063697 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation
|
ISO
|
U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK1 protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:31875996 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation multiple interactions
|
ISO
|
[Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK3 protein U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:31875996 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mpo
|
myeloperoxidase
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of MPO mRNA
|
CTD |
PMID:18063697 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G
|
Mrc1
|
mannose receptor, C type 1
|
decreases expression
|
ISO
|
Dimethylformamide results in decreased expression of MRC1 mRNA
|
CTD |
PMID:37995826 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G
|
Mrc2
|
mannose receptor, C type 2
|
decreases expression
|
ISO
|
Dimethylformamide results in decreased expression of MRC2 mRNA
|
CTD |
PMID:37995826 |
|
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
|
|
G
|
Mre11
|
MRE11 homolog, double strand break repair nuclease
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of MRE11 mRNA; Dimethylformamide results in increased expression of MRE11 protein
|
CTD |
PMID:26387567 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G
|
Ncf1
|
neutrophil cytosolic factor 1
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of NCF1 mRNA
|
CTD |
PMID:18063697 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:22,485,451...22,494,646
|
|
G
|
Nefh
|
neurofilament heavy chain
|
affects expression
|
EXP
|
Dimethylformamide affects the expression of NEFH mRNA
|
CTD |
PMID:22954530 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:79,830,362...79,840,351
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions decreases activity increases expression
|
ISO
|
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein] allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NFE2L2 protein]
|
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions increases phosphorylation
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of NLRP3 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NLRP3 protein]
|
CTD |
PMID:37995826 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NOS2 mRNA]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NOS2 protein] Dimethylformamide results in increased expression of NOS2 mRNA; Dimethylformamide results in increased expression of NOS2 protein
|
CTD |
PMID:37995826 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions decreases expression increases expression
|
ISO
|
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein] Dimethylformamide results in decreased expression of NQO1 mRNA; Dimethylformamide results in decreased expression of NQO1 protein Dimethylformamide results in increased expression of NQO1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NQO1 protein]
|
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
EXP
|
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein
|
CTD |
PMID:20097184 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of PTGS2 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of PTGS2 protein]
|
CTD |
PMID:37995826 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of PYCARD protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of PYCARD protein]
|
CTD |
PMID:37995826 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
|
|
G
|
Rad50
|
RAD50 double strand break repair protein
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of RAD50 mRNA; Dimethylformamide results in increased expression of RAD50 protein
|
CTD |
PMID:26387567 |
|
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G
|
Rad51
|
RAD51 recombinase
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of RAD51 mRNA; Dimethylformamide results in increased expression of RAD51 protein
|
CTD |
PMID:26387567 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases phosphorylation
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased phosphorylation of RELA protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of RELA protein]; Dimethylformamide results in increased expression of and results in increased phosphorylation of RELA protein
|
CTD |
PMID:37995826 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
decreases degradation increases phosphorylation multiple interactions
|
ISO
|
Dimethylformamide results in decreased degradation of RXRA protein [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; [Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein Alitretinoin inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]
|
CTD |
PMID:31875996 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G
|
Sod1
|
superoxide dismutase 1
|
increases expression multiple interactions
|
ISO
|
Dimethylformamide results in increased expression of SOD1 mRNA; Dimethylformamide results in increased expression of SOD1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of SOD1 protein]
|
CTD |
PMID:35238128 PMID:37995826 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
multiple interactions
|
ISO
|
Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 1-hydroxypyrene]; Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol]
|
CTD |
PMID:14570759 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G
|
Sult2a1
|
sulfotransferase family 2A member 1
|
multiple interactions
|
ISO
|
Dimethylformamide inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene]
|
CTD |
PMID:14570759 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases secretion increases expression
|
ISO
|
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of TNF protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of TNF mRNA]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased secretion of TNF protein]; Dimethylformamide results in increased expression of and results in increased secretion of TNF protein
|
CTD |
PMID:37995826 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Tnfsf10
|
TNF superfamily member 10
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of TNFSF10 mRNA; Dimethylformamide results in increased expression of TNFSF10 protein
|
CTD |
PMID:18063697 |
|
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression
|
ISO
|
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] Dimethylformamide results in increased expression of TP53 protein modified form
|
CTD |
PMID:29984871 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G
|
Trim28
|
tripartite motif-containing 28
|
decreases expression
|
ISO
|
Dimethylformamide results in decreased expression of TRIM28 mRNA
|
CTD |
PMID:35238128 |
|
NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:73,652,709...73,659,380
|
|
G
|
Xrcc2
|
X-ray repair cross complementing 2
|
increases expression affects expression
|
ISO
|
Dimethylformamide results in increased expression of XRCC2 protein Dimethylformamide affects the expression of XRCC2 mRNA
|
CTD |
PMID:26387567 |
|
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
|
|
G
|
Xrcc3
|
X-ray repair cross complementing 3
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of XRCC3 mRNA; Dimethylformamide results in increased expression of XRCC3 protein
|
CTD |
PMID:26387567 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G
|
Zp2
|
zona pellucida glycoprotein 2
|
increases expression
|
ISO
|
Dimethylformamide results in increased expression of ZP2 mRNA
|
CTD |
PMID:35238128 |
|
NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:174,513,511...174,525,288
|
|